Why are we still waiting for a male contraceptive pill?
Ian Sample speaks to bioethicist Prof Lisa Campo-Engelstein of the
University of Texas and Prof Chris Barratt from the University of
Dundee to find out why male contraceptives have been so difficult
to develop, and what kind of options are in the pipeline
16 Minuten
Podcast
Podcaster
Beschreibung
vor 1 Jahr
Despite research into a male contraceptive pill starting around the
same time as its female counterpart, no product has ever made it to
market. But that could soon change, with a new non-hormonal male
pill entering human trials in the UK late last year. Ian Sample
speaks to bioethicist Prof Lisa Campo-Engelstein of the University
of Texas and Prof Chris Barratt from the University of Dundee about
why male contraceptives have been so difficult to develop, and what
kind of options are in the pipeline. Help support our independent
journalism at theguardian.com/sciencepod
same time as its female counterpart, no product has ever made it to
market. But that could soon change, with a new non-hormonal male
pill entering human trials in the UK late last year. Ian Sample
speaks to bioethicist Prof Lisa Campo-Engelstein of the University
of Texas and Prof Chris Barratt from the University of Dundee about
why male contraceptives have been so difficult to develop, and what
kind of options are in the pipeline. Help support our independent
journalism at theguardian.com/sciencepod
Weitere Episoden
18 Minuten
vor 9 Monaten
17 Minuten
vor 9 Monaten
22 Minuten
vor 9 Monaten
19 Minuten
vor 9 Monaten
16 Minuten
vor 9 Monaten
In Podcasts werben
Kommentare (0)